Cancer Associated Thrombosis
Cancer is the highest single risk factor for thrombosis.
Thrombosis UK joined with organizations representing patients, nurses and health experts to call on the European Commission to take into account cancer-related complications as it designs its European Beating Cancer Plan.
Patients and experts draw attention to cancer-related conditions.
It is estimated that up to 20% of patients with cancer experience venous thrombosis (VTE).
There is a fivefold higher annual incidence of thrombosis among cancer patients, with about 1 in 1,000 in the general population and 1 in 200 in cancer patients.
Warwick Clinical Trials Unit – selected Cancer associated thrombosis – a patient perspective
Cancer-associated thrombosis awareness survey - Results report - October 2018
European Cancer Patient Coalition
With support from LEO Pharma
Carried out by Quality Health Limited